New Jersey Attorneys Who Get Results

New Jersey Attorney, New Jersey Medical Malpractice Attorney, NJ Personal Injury Lawyers

Meet Gary Shapiro and David Sternlieb, two experienced New Jersey attorneys who know how to get results. At Shapiro & Sternlieb, we are 100% dedicated to providing our clients with the highest quality legal representation. Through our hard work, persistence and with more than 60 years of combined legal experience, we work hard to protect your rights. As expert lawyers, we have the resources and knowledge to handle complex cases. We pride ourselves on our concern for you as an individual as well as for your legal rights.

Shapiro & Sternlieb: New Jersey Personal Injury Lawyers

auto accident lawyer ,NJ Personal Injury Lawyers, New Jersey Medical Malpractice Attorney

At Shapiro & Sternlieb, your case is our priority. Our attorneys combine outstanding client services with a thorough knowledge of the law and a firm understanding of the latest technology available. Our vast network of legal, medical and professional experts are available to present the best case for you. Located in Manalapan, New Jersey, our lawyers maintain flexible hours to meet your needs. We offer morning, evening or weekend hours, as well as visits to home or hospital, if needed. Our attorneys and staff bring the highest standards of expertise, preparation, concern, diligence, integrity and skill to each case. We take time to return your calls and to ensure each question is answered. You are included every step of the way!

News & Articles

Salmonella Outbreak Linked To Tainted Peanut Butter
CARBON NANOTUBES: A Closer Look at Miracle Technology's Potential Side Effects

Practice Areas

AsbestosInfant & Child Injuries
Auto AccidentsDUI (DWI) Matters
DiscriminationBirth Injuries
Defective ProductsBrain Injury
Burn InjuriesCerebral Palsy
Criminal DefenseClass Action Lawsuits
Construction AccidentsDog Bites
Erbs PalsyFailure To Diagnose Cancer
Gas ExplosionsHead Injury
Juvenile CourtLung Cancer - Mesothelioma
Medical MalpracticeMotorcycle Accidents
NegligenceNegligent Security
Nursing Home AbusePersonal Injury
Premises LiabilitySexual Harassment
Slip & Fall AccidentsTraffic Violations
Truck AccidentsWorkplace Injuries
Wrongful Discharge

FDA Consumer Health Information Updates

What's in a Name? What Every Consumer Should Know About Foods and Flavors

Wed, 21 Sep 2016 08:00:00 -0400

Is flavor labeling on food packages misleading? FDA helps ensure that it isn't.

4 Medication Safety Tips for Older Adults

Tue, 20 Sep 2016 09:00:00 -0400

The older you get, the more likely you are to use additional medicines, which can increase the chance of harmful drug effects including interactions. So consider these safety tips (and share them with your loved ones) when taking prescriptions, over-the-counter medicines, herbal preparations, and supplements.

FDA: Cutting-Edge Technology Sheds Light on Antibiotic Resistance

Thu, 15 Sep 2016 08:30:00 -0400

FDA is using whole genome sequencing to determine if antibiotic resistant strains of bacteria found in other countries are also present in the U.S.

FDA Facilitates Research on Earlier Stages of Alzheimer's Disease

Tue, 13 Sep 2016 08:00:00 -0400

To advance urgently needed research in Alzheimer's disease, FDA is engaging with researchers, drug companies, and the public as they design new clinical studies for promising drugs.

Traumatic Brain Injury: FDA Research and Actions

Thu, 08 Sep 2016 08:00:00 -0400

Traumatic brain injury (TBI) can happen to anyone. And these types of injuries, which include concussions, contribute to a substantial number of emergency room visits (and even deaths) each year. Learn about TBI and the FDA's related research and regulatory activities.

Food and Drug Administration--Press Releases

FDA warns against the use of homeopathic teething tablets and gels

Fri, 30 Sep 2016 15:09:00 -0400

The U.S. Food and Drug Administration is warning consumers that homeopathic teething tablets and gels may pose a risk to infants and children. The FDA recommends that consumers stop using these products and dispose of any in their possession.

FDA Statement from Todd Simpson, FDA Chief Information Officer (CIO) on GAO Report Regarding FDA’s IT Security Program

Thu, 29 Sep 2016 12:21:00 -0400

Information security and the protection of industry and public health information are among the FDA’s highest priorities and we do not take lightly the recommendations provided by the GAO in its June 2016 report.

FDA approves first automated insulin delivery device for type 1 diabetes

Wed, 28 Sep 2016 13:09:00 -0400

The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.

FDA approves expanded indications for Ilaris for three rare diseases

Fri, 23 Sep 2016 16:39:00 -0400

The U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). The new indications are for rare and serious auto-inflammatory diseases in adult and pediatric patients:

FDA approves Amjevita, a biosimilar to Humira

Fri, 23 Sep 2016 16:05:00 -0400

The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.

Recall Listing[min]&field_rc_date_value[max]&field_rc_heading_value=&field_rc_hazard_description_value=&field_rc_manufactured_in_value=&field_rc_manufacturers_value=